Novartis Horsham Research Centre, Horsham, West Sussex RH12 5AB, United Kingdom
Correspondence: Gabor Jarai, Ph.D., Novartis Horsham Research Centre, Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom. E-mail: gabor.jarai{at}pharma.novartis.com
The migration of neutrophils into sites of acute and chronic inflammation is mediated by chemokines. We used degenerate-primer reverse transcriptase-polymerase chain reaction (RT-PCR) to analyze chemokine receptor expression in neutrophils and identify novel receptors. RNA was isolated from human peripheral blood neutrophils and from neutrophils that had been stimulated for 5 h with granulocyte-macrophage colony-stimulating factor or by coculturing with primary human bronchial epithelial cells. Amplification products were cloned, and clone redundancy was determined. Seven known G-protein-coupled receptors were identified among 38 clones—CCR1, CCR4, CXCR1, CXCR2, CXCR4, HM63, and FPR1—as well as a novel gene, EX33. The full-length EX33 clone was obtained, and an in silico approach was used to identify the putative murine homologue. The EX33 gene encodes a 396-amino-acid protein with limited sequence identity to known receptors. Expression studies of several known chemokine receptors and EX33 revealed that resting neutrophils expressed higher levels of CXCRs and EX33 compared with activated neutrophils. Northern blot experiments revealed that EX33 is expressed mainly in bone marrow, lung, and peripheral blood leukocytes. Using RT-PCR analysis, we showed more abundant expression of EX33 in neutrophils and eosinophils, in comparison with that in T- or B-lymphocytes, indicating cell-specific expression among leukocytes.
Key Words: chemokine receptors • neutrophils • eosinophils • degenerate PCR
This article has been cited by other articles:
 |
|
 |
|
  M. Watanabe, W. Matsuyama, Y. Shirahama, H. Mitsuyama, K.-i. Oonakahara, S. Noma, I. Higashimoto, M. Osame, and K. Arimura Dual Effect of AMD3100, a CXCR4 Antagonist, on Bleomycin-Induced Lung Inflammation J. Immunol., May 1, 2007; 178(9): 5888 - 5898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wang, X. Wu, N. Simonavicius, H. Tian, and L. Ling Medium-chain Fatty Acids as Ligands for Orphan G Protein-coupled Receptor GPR84 J. Biol. Chem., November 10, 2006; 281(45): 34457 - 34464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gouwy, S. Struyf, J. Catusse, P. Proost, and J. Van Damme Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration J. Leukoc. Biol., July 1, 2004; 76(1): 185 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Brink, S.-E. Dahlen, J. Drazen, J. F. Evans, D. W. P. Hay, G. E. Rovati, C. N. Serhan, T. Shimizu, and T. Yokomizo International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor Pharmacol. Rev., March 1, 2004; 56(1): 149 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Ness, C. M. Hogaboam, R. M. Strieter, and S. L. Kunkel Immunomodulatory Role of CXCR2 During Experimental Septic Peritonitis J. Immunol., October 1, 2003; 171(7): 3775 - 3784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Jones, S. Holden, L. Tenaillon, U. Bhatia, K. Seuwen, P. Tranter, J. Turner, R. Kettle, R. Bouhelal, S. Charlton, et al. Expression and Characterization of a 5-oxo-6E,8Z,11Z,14Z-Eicosatetraenoic Acid Receptor Highly Expressed on Human Eosinophils and Neutrophils Mol. Pharmacol., March 1, 2003; 63(3): 471 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Schuh, K. Blease, and C. M. Hogaboam CXCR2 Is Necessary for the Development and Persistence of Chronic Fungal Asthma in Mice J. Immunol., February 1, 2002; 168(3): 1447 - 1456. [Abstract] [Full Text] [PDF]
|
|
